BioSpace News Archive

Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate into clinical trials

Sosei Group Corporation (“the Company”; TSE: 4565), today announce the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug candidate into a first-in-human trial.

July 21, 2022
·
7 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 22, 2022

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 405,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

July 21, 2022
·
1 min read
Biotech Bay

Astellas Unveils Plans to Open New Biotech Campus in South San Francisco

Astellas Pharma Inc. announced plans to create an integrated biotechnology campus in South San Francisco as its West Coast innovation and research center.

July 21, 2022
·
5 min read
BioMidwest

TIANGEN to Participate in the 2022 AACC Meeting

TIANGEN, a leading brand in the field of nucleic acid purification in China, has announced its participation in the 2022 American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo from July 26 to 28 in Chicago where it will be officially launching its brand in the US market.

July 21, 2022
·
2 min read
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

PharmaCyte Biotech, Inc. announced today that it has commenced the pilot phase of its two-phase pig study.

July 21, 2022
·
6 min read
Deals

LumiraDx Announces Pricing of Public Offering of Common Shares and Concurrent Private Placement

LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced the pricing of its underwritten public offering of 43,000,000 common shares at a price to the public of $1.75 per share.

July 21, 2022
·
6 min read
Biotech Beach

Evofem Partners with a360 Media to Support Phexxi® Prescription Growth

Evofem Biosciences, Inc., announced an agreement between Evofem and a360 Media under which Phexxi® branded content will appear in some of the most widely read entertainment and lifestyle magazines and websites in the U.S.

July 21, 2022
·
3 min read
NLS Pharmaceutics Announces Positive Opinion from European Regulators to Grant Orphan Drug Designation for Mazindol ER in Idiopathic Hypersomnia

NLS Pharmaceutics Ltd. announces that the European Medicines Agency (EMA) Committee for Orphan Medical Products (COMP) has issued a positive opinion to grant Orphan Drug Designation for Mazindol ER.

July 21, 2022
·
8 min read
Biotech Beach

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

AXIM Biotechnologies, Inc. announced today that its CEO John Huemoeller has been featured on the Vision is More Than 20/20™ podcast.

July 21, 2022
·
3 min read
BioMidwest

Brand Institute’s President of Canadian Regulatory Affairs Updates Brand Name Assessment Methodology Based on Health Canada Trends

Brand Institute, the global leader in pharmaceutical and healthcare-related name development, is pleased to announce new processes in its workflow.

July 21, 2022
·
2 min read